Cargando…

The novel desmopressin analogue [V(4)Q(5)]dDAVP inhibits angiogenesis, tumour growth and metastases in vasopressin type 2 receptor-expressing breast cancer models

Desmopressin (dDAVP) is a safe haemostatic agent with previously reported antitumour activity. It acts as a selective agonist for the V2 vasopressin membrane receptor (V2r) present on tumour cells and microvasculature. The purpose of this study was to evaluate the novel peptide derivative [V(4)Q(5)]...

Descripción completa

Detalles Bibliográficos
Autores principales:	GARONA, JUAN, PIFANO, MARINA, ORLANDO, ULISES D., PASTRIAN, MARIA B., IANNUCCI, NANCY B., ORTEGA, HUGO H., PODESTA, ERNESTO J., GOMEZ, DANIEL E., RIPOLL, GISELLE V., ALONSO, DANIEL F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4441290/ https://www.ncbi.nlm.nih.gov/pubmed/25846632 http://dx.doi.org/10.3892/ijo.2015.2952

Ejemplares similares

Preclinical Efficacy of [V(4)Q(5)]dDAVP, a Second Generation Vasopressin Analog, on Metastatic Spread and Tumor-Associated Angiogenesis in Colorectal Cancer
por: Garona, Juan, et al.
Publicado: (2019)

Vasopressin Analog [V(4)Q(5)]dDAVP Exerts Cooperative Anticancer Effects in Combination With Low-Dose 5-Fluorouracil on Aggressive Colorectal Cancer Models
por: Sobol, Natasha T., et al.
Publicado: (2023)

Reduction of tumor angiogenesis induced by desmopressin in a breast cancer model
por: Ripoll, Giselle V., et al.
Publicado: (2013)

Commentary: Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer
por: Ripoll, Giselle V., et al.
Publicado: (2020)

Vasopressin Bolus Protocol Compared to Desmopressin (DDAVP) for Managing Acute, Postoperative Central Diabetes Insipidus and Hypovolemic Shock
por: Shukla, Anukrati, et al.
Publicado: (2017)

Administration of the vasopressin analog desmopressin for the management of bleeding in rectal cancer patients: results of a phase I/II trial
por: Iseas, Soledad, et al.
Publicado: (2020)

Peptide Agonists of Vasopressin V2 Receptor Reduce Expression of Neuroendocrine Markers and Tumor Growth in Human Lung and Prostate Tumor Cells
por: Pifano, Marina, et al.
Publicado: (2017)

Coronary Spastic Angina Induced after Oral Desmopressin (DDAVP) Administration
por: Adachi, Yusuke, et al.
Publicado: (2016)

SUN-410 Central Diabetes Insipidus Refractory to Oral Desmopressin (DDAVP)
por: Burdea, Liliana, et al.
Publicado: (2019)

Metastasis: Recent Discoveries and Novel Perioperative Treatment Strategies with Particular Interest in the Hemostatic Compound Desmopressin
por: Alonso, D.F, et al.
Publicado: (2011)

dDAVP Downregulates the AQP3-Mediated Glycerol Transport via V1aR in Human Colon HCT8 Cells
por: Centrone, Mariangela, et al.
Publicado: (2022)

A phase II dose-escalation trial of perioperative desmopressin (1-desamino-8-d-arginine vasopressin) in breast cancer patients
por: Weinberg, Ruth S, et al.
Publicado: (2015)

Anticancer activity of repurposed hemostatic agent desmopressin on AVPR2-expressing human osteosarcoma
por: Sobol, Natasha Tatiana, et al.
Publicado: (2021)

Desmopressin/vasopressin: Lack of efficacy: case report
Publicado: (2021)

The Functional Interaction between Acyl-CoA Synthetase 4, 5-Lipooxygenase and Cyclooxygenase-2 Controls Tumor Growth: A Novel Therapeutic Target
por: Orlando, Ulises D., et al.
Publicado: (2012)

Management of Severe Hyponatremia: Infusion of Hypertonic Saline and Desmopressin or Infusion of Vasopressin Inhibitors?
por: Tzamaloukas, Antonios H., et al.
Publicado: (2014)

DDAVP Might Reduce the Risk of Preeclampsia in Pregnant Women with VWF Deficiency
por: Jahromi, Alireza Hamidian, et al.
Publicado: (2013)

Vasopressin and its analogues in shock states: a review
por: Demiselle, Julien, et al.
Publicado: (2020)

Administration of DDAVP did not improve the pharmacokinetics of FVIII concentrate in a clinically significant manner
por: Loomans, Janneke I, et al.
Publicado: (2018)

Comparative response of Desmopressin versus Combination Therapy (Desmopressin + Oxybutynin) in Children with Nocturnal Enuresis
por: Kazi, Asiya, et al.
Publicado: (2020)

MON-435 The Responsiveness To Ddavp Test Predicts Usp8 Mutation In Patients With Cushing's Disease
por: Shichi, Hiroki, et al.
Publicado: (2019)

cAMP-Epac1 signaling is activated in DDAVP-induced endolymphatic hydrops of guinea pigs
por: Chuan, Wang, et al.
Publicado: (2023)

Effect of a Somatostatin Analogue on the Vasopressin Pathway in Patients With ADPKD
por: Messchendorp, A. Lianne, et al.
Publicado: (2019)

Vasopressin and Its Analogues: From Natural Hormones to Multitasking Peptides
por: Glavaš, Mladena, et al.
Publicado: (2022)

Antifibrinolytic Agents: Aprotinin, and Desmopressin
por: Bajaj, Pramila
Publicado: (2009)

Desmopressin Acetate in Intracranial Haemorrhage
por: Kapapa, Thomas, et al.
Publicado: (2014)

Safety of renal biopsy bleeding prophylaxis with desmopressin
por: Barrios, R. Haridian Sosa, et al.
Publicado: (2021)

A comparison of the efficacy and tolerability of treating primary nocturnal enuresis with Solifenacin Plus Desmopressin, Tolterodine Plus Desmopressin, and Desmopressin alone: a randomized controlled clinical trial
por: Ghanavati, Parvin Mousavi, et al.
Publicado: (2020)

Treatment with ddAVP improves platelet-based coagulation in a rat model of traumatic hemorrhagic shock
por: Wirtz, Mathijs R, et al.
Publicado: (2022)

Low COAT platelets are frequent in patients with bleeding disorders of unknown cause (BDUC) and can be enhanced by DDAVP
por: Segot, Amandine, et al.
Publicado: (2022)

Use of Desmopressin in Hyponatremia: Foe and Friend
por: Achinger, Steven G., et al.
Publicado: (2019)

Delay in desmopressin therapy: Disaster in waiting
por: Kroll, Christian, et al.
Publicado: (2022)

Comparison of combined treatment with desmopressin plus oxybutynin and desmopressin plus tolterodine in treatment of children with primary nocturnal enuresis
por: Azarfar, Anoush, et al.
Publicado: (2015)

Efficacy of desmopressin in treatment of nocturia in elderly men
por: Rezakhaniha, Bijan, et al.
Publicado: (2011)

Melatonin’s Effect on the Efficacy of Desmopressin in the Treatment of Enuresis
por: Ferrara, Pietro, et al.
Publicado: (2016)

Korean guideline of desmopressin for the treatment of nocturia in men
por: Hwang, Eu Chang, et al.
Publicado: (2022)

Vasopressin and Vasopressin Receptor Antagonists
por: Oh, Yun Kyu
Publicado: (2008)

Exposure to anticancer drugs modulates the expression of ACSL4 and ABCG2 proteins in adrenocortical carcinoma cells
por: Ríos Medrano, Mayra Agustina, et al.
Publicado: (2023)

Home blood sodium monitoring, sliding-scale fluid prescription and subcutaneous DDAVP for infantile diabetes insipidus with impaired thirst mechanism
por: Hameed, Shihab, et al.
Publicado: (2012)

Pitfalls in Interventional Pain Medicine: Hyponatremia after DDAVP for a Patient with Von Willebrand Disease Undergoing an Epidural Steroid Injection
por: Khan, Talal W., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_s1s1217jitb0p45t1dm2pd7j6l